Matthew L. Posard - 30 Nov 2021 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
30 Nov 2021
Net transactions value
+$225,505
Form type
4
Filing time
01 Dec 2021, 20:41:03 UTC
Previous filing
09 Jun 2021
Next filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $91,400 +20,000 $4.57 20,000 30 Nov 2021 Direct
transaction NAUT Common Stock Purchase $45,000 +10,000 +50% $4.50 30,000 01 Dec 2021 Direct
transaction NAUT Common Stock Purchase $44,612 +10,000 +33% $4.46 40,000 01 Dec 2021 Direct
transaction NAUT Common Stock Purchase $44,493 +10,000 +25% $4.45 50,000 01 Dec 2021 Direct
holding NAUT Common Stock 100,000 30 Nov 2021 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Matthew and Elizabeth Posard Trust. The reporting person is the Trustee of the Matthew and Elizabeth Posard Trust.